Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 11: 137-154, 1965;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjerre, S.
Right arrow Articles by Porter, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjerre, S.
Right arrow Articles by Porter, C. J.

Clinical Chemistry, Vol 11, 137-154, Copyright © 1965 by the American Association for Clinical Chemistry

Simultaneous Determination of Barbiturates and Salicylates by Ultraviolet Spectrophotometry

Solveig Bjerre 1 and C. J. Porter 2

1 Division of Chemistry and Biochemistry, Department of Laboratories, Toronto General Hospital, Toronto, Canada.
2 Division of Chemistry amid Biochemistry, Department of Laboratories, Toronto General Hospital, Toronto, Canada.

A rapid method based on UV spectrophotometry is described for simultaneous determination of salicylates and barbiturates in serum. While barbiturates have no absorbance above 280 mµ and extracted normal serum has insignificant absorbance, salicylate has a maximal absorbance peak at 296 mµ, which is proportional to concentration. The barbiturate concentration can be calculated from absorbance differences between pH 10 and pH 2, pH 13 and pH 2, or pH 13 and pH 10, at wave lengths 239 mµ, 253 mµ, and 259 mµ respectively. These absorbance differences can be shown to relate linearly with concentration. The error involved in barbiturate determinations performed when salicylate is present is discussed, and a compensation for the presence of salicylate is derived from absorbance measurements at 296 mµ.

The extraction and the various factors involved (e.g., pH, and presence of Na2SO4) in obtaining quantitative recovery of both barbiturates and salicylates are described.

As the UV absorption spectra of some barbiturates but not of salicylates are changed during alkaline treatment, a partial differentiation of barbiturates based on the rate of alkaline hydrolysis is made possible.

Criteria for the presence of salicylates and barbiturates and the detection of interference from other drugs such as bemegride, glutethimide, and sulfonamides are discussed.

Submitted on November 12, 1963
Accepted on July 8, 1964






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the American Association for Clinical Chemistry.